US Broker Ratings

Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a 16.30% Potential Upside in the Diagnostics Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $42.54 billion, this Santa..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 30% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (AZN), a leading giant in the healthcare sector, has been catching the eye of investors with its promising potential upside of 30.63%. As a major player in the..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.54% Potential Upside Beckons Investors

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, is garnering significant attention from investors looking to capitalize on its promising growth potential. With a market cap of..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and a 17.28% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, is making waves in the healthcare industry with its robust portfolio of pharmaceutical products targeting a range of..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 20% Potential Upside with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its innovative diagnostics and research solutions. Based in Palo Alto, California, the..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity

Inspire Medical Systems, Inc. (NASDAQ: INSP), a notable player in the healthcare sector, specializes in pioneering medical devices designed to tackle obstructive sleep apnea (OSA). With a market capitalization of..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring a Potential 61.45% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector with its ambitious focus on developing breakthrough treatments for cancer. The company’s lead candidate, ivonescimab, is at the..

iRhythm Holdings, Inc. (IRTC): Analyst Ratings Signal a Promising 43% Upside for Investors

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its robust growth potential in the healthcare sector, specifically within the medical devices industry. The San Francisco-based company specializes in..

Oscar Health, Inc. (OSCR)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: Biotech Growth with 51% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands as a noteworthy player in the biotechnology sector, carving a niche in the healthcare industry with its focus on novel muscle activators and inhibitors. Headquartered..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with 76% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, presents an intriguing investment opportunity with a potential upside of 76.72%, according to analyst ratings. The company’s focus..

Qiagen N.V. (QGEN) Stock Analysis: Exploring the 5.98% Potential Upside for Investors

Qiagen N.V. (NASDAQ: QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is headquartered in Venlo, the Netherlands. With a market capitalization of $8.98..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 4.14% Potential Upside Amidst Market Volatility

Molina Healthcare Inc (MOH), a key player in the healthcare plans industry, has captured the attention of investors with its robust market presence and potential for a 4.14% upside. Headquartered..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 30% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable entity within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $42.18 billion, IDEXX has..

Insmed Incorporated (INSM) Stock Analysis: Capturing a 58% Potential Upside with Innovative Biotech Solutions

Insmed Incorporated (NASDAQ: INSM) is making waves in the biotechnology sector, presenting a compelling investment opportunity with a remarkable 58.51% potential upside based on current analyst ratings. With a market..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Assessing a Promising 29.74% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $2.48 billion, this American..

Bio-Techne Corp (TECH) Stock Analysis: Navigating Its Current Valuation and Growth Potential

For investors seeking opportunities within the biotechnology sector, Bio-Techne Corp (NASDAQ: TECH) presents a compelling case with its steady presence in the healthcare industry and a market cap of $11.36..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 29.99% Upside in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands poised at the forefront of the healthcare sector, offering investors an intriguing opportunity with a potential upside of 29.99%. With a market capitalization of..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Evaluating a 51.72% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at an intriguing crossroads for investors focusing on the biotechnology sector. With a significant market cap of $9.65 billion, Ionis presents a unique investment..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating a 13.17% Potential Upside Amid Market Challenges

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) is a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With its headquarters in Hyderabad, India, Dr...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds